An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients. Boekhoff MR, Defize IL, Borggreve AS, van Hillegersberg R, et al. Radiother Oncol 2021 Jul 5. pii: S0167-8140(21)06626.

Read + Share

Amedeo Smart

Independent Medical Education

Boekhoff MR, Defize IL, Borggreve AS, van Hillegersberg R, et al. An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients. Radiother Oncol 2021 Jul 5. pii: S0167-8140(21)06626.
PMID: 34237345